Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
24 Analysts have issued a Qiagen forecast:
24 Analysts have issued a Qiagen forecast:
| Jun '25 | 
    +/-
   
    %
   | ||
| Revenue | 1,756 1,756 | 
      
        
        5%
      
      
        
        5%
      
 | |
| Gross Profit | 1,127 1,127 | 
      
        
        7%
      
      
        
        7%
      
 | |
| EBITDA | 478 478 | 
      
        
        21%
      
      
        
        21%
      
 | |
| EBIT (Operating Income) EBIT | 472 472 | 
      
        
        22%
      
      
        
        22%
      
 | |
| Net Profit | 321 321 | 
      
        
        414%
      
      
        
        414%
      
 | |
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
| Head office | United States | 
| CEO | Thierry Bernard | 
| Employees | 5,232 | 
| Founded | 1996 | 
| Website | www.qiagen.com | 
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


